Medical/Pharmaceuticals

More Ingredients, Better Supplements? Totaria Shares What Midlife Women Should Look For

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- As World Menopause Day approaches, Totaria, a premium American nutritional supplement brand, encourages women to look more closely at how they evaluate multi-ingredient supplements and manage ...

2026-10-15 23:12 2513

MHTC AND MAYBANK PARTNER TO BRING MALAYSIA HEALTHCARE CLOSER TO ASEAN CUSTOMERS

Multi-year collaboration combines Malaysia Healthcare ecosystem with Maybank's regional reach to support a more connected healthcare and wellness journey across ASEAN KUALA LUMPUR, Malaysia, Oct. 15, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) and Malayan Banking Berhad (Mayba...

2026-10-15 21:15 3175

Four Leading Institutions Complete Initial Clinical Experience with Spectrum Dynamics Medical's All-Energy Digital SPECT/CT

Experience at institutions from across the globe demonstrated theranostics and imaging across the validated 40-400 keV range and up to 500 keV, with additional scientific and clinical feasibility experience obtained at higher energies, including applications involving Tc-99m, I-123, Lu-177, I-131...

2026-10-15 20:00 2482

The World Egg and Sperm Bank (TWESB) Joins IVI Institute to Expand Access to Reproductive Solutions

SCOTTSDALE, Ariz., Oct. 15, 2026 /PRNewswire/ -- IVI Institute, the global leader in fertility care, today announced that The World Egg and Sperm Bank (TWESB), a trusted provider of donor egg and donor sperm services, has joined its global group. This acquisition expands access to high quality re...

2026-10-15 19:51 1919

Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform

Proprietary BRiSC™ platform to advance the discovery and development of next-generation dual-targeting siRNA medicines Initial focus on prevalent metabolic dysfunctions where complex disease biology and overlapping comorbidities will benefit from coordinated modulation of multiple therapeutic ta...

2026-10-15 19:30 2241

OrbiMed Raises $3 Billion Across Global and Asia Private Equity Funds

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- OrbiMed , a leading global healthcare investment firm, is pleased to announce that it has raised $3 billion in commitments for two new privat...

2026-10-15 19:30 2413

One Journey, Two Experiences: Heal And Explore In Selangor

JAKARTA, Indonesia, Oct. 15, 2026 /PRNewswire/ -- Selangor continues to strengthen its position as a preferred medical tourism destination in Southeast Asia, particularly among Indonesian travellers, through its combination of internationally accredited healthcare facilities, excellent accessibil...

2026-10-15 17:06 3696

HMI Medical Unveils New Brand Identities Across Its Healthcare Facilities in Malaysia As Regional Cross-border Healthcare Grows

The refreshed identities of HMI Medical's hospitals and medical centre in Malaysia signal the Group's commitment to deliver more with care by sparking change for the future of healthcare SINGAPORE and KUALA LUMPUR, Malaysia, Oct. 15, 2026 /PRNewswire/ -- HMI Medical is strengthening its regional...

2026-10-15 12:25 3743

NTL HEALTHCARE Launches On-Premises AI Solution 'CerviCARE® AI AT' Globally

Supports Local AI Analysis and Data Management, Retains Core CerviCARE® AI Features, and Adds DICOM File Generation SEONGNAM, South Korea, Oct. 15, 2026 /PRNewswire/ -- NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its AI-...

2026-10-15 10:00 2572

Opella: New study demonstrates successful cough treatment extends beyond symptom relief

PARIS, Oct. 15, 2026 /PRNewswire/ -- A new real-world study from Opella, the maker of Mucosolvan and Bisolvon, provides pharmacists with compelling evidence that the success of a cough treatment should be measured by its impact on a patient's overall well-being, alongside traditional symptomatic ...

2026-10-15 07:01 2167

Lunit SCOPE Reveals HER2 Expression Differences Linked to Treatment Response Beyond Conventional Testing in Nature Medicine Study

AI-powered whole-slide analysis provides insights into treatment response beyond conventional HER2 classification SEOUL, South Korea, Oct. 14, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced findings from a study p...

2026-10-14 21:00 2664

Neurophet Honored with Two Awards at the BioSpectrum Asia Excellence Awards 2026

* Receives Awards for MedTech Innovation and AI-Driven Clinical Development; Only Korean Company Recognized in Two Categories * Recognized for its capabilities in AI-driven clinical support and ICL services, with plans to expand partnerships with global CROs SEOUL, South Korea, Oct. 14, 2026 /...

2026-10-14 21:00 2293

Continuity Biosciences Awarded $9.6 Million Grant to Advance Ultra-Long-Acting Implant for HIV Prevention

Funding supports development of a subcutaneous implant designed to deliver HIV prevention medicine for multiple years from a single placement, advancing toward an IND submission and initiation of a first-in-human Phase 1 study BRADENTON, Fla. and SEATTLE, Oct. 14, 2026 /PRNewswire/ -- Continuity ...

2026-10-14 20:00 2091

MIRACELL to Host Stem Cell Science Day 2026 in Los Angeles, Featuring International Clinical Insights in Regenerative Medicine

- Leading South Korean and U.S. medical experts to share clinical insights into regenerative medicine - Austrian clinical study on 47 ACL rupture patients treated with SMART M-CELL published in peer-reviewed journal LOS ANGELES, Oct. 14, 2026 /PRNewswire/ -- Miracell U.S. Inc., the U.S. subsidi...

2026-10-14 19:00 1835

Prof. Gang Shen Named Among World's Top 2% Scientists for Fourth Consecutive Year

SHANGHAI, Oct. 14, 2026 /PRNewswire/ -- Prof. Gang Shen of Taikang ByBo Dental has been named among theWorld's Top 2% Scientists for the fourth consecutive year, according to the ninth edition of the database jointly released by Stanford University and Elsevier. Prof. Shen has been recognised on...

2026-10-14 18:18 1399

NueCell Bio Joins CIRM's Industry Resource Partner Program to Support California's Stem Cell and Gene Therapy Innovators

SAN DIEGO, Oct. 14, 2026 /PRNewswire/ -- NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced today it has joined the Industry Resource Partnership (IRP) Program of the California Institute for Regenerative Medici...

2026-10-14 15:00 2288

Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM

MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that 20 company-related abstracts will be presented at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in ...

2026-10-14 13:00 3111

Likang Life Sciences to Showcase Advances in Personalized Cancer Immunotherapy at Abu Dhabi Future Health Summit 2026

BEIJING, Oct. 14, 2026 /PRNewswire/ -- Likang Life Sciences will serve as a sponsor and exhibitor at the Abu Dhabi Future Health Summit 2026, to be held October 20–22 at the ADNEC Centre in Abu Dhabi, the United Arab Emirates. Shannon Cheung, Co-Founder and Vice Chairman of Likang, will join a pa...

2026-10-14 10:25 2665

Osara Health and Medibank partner to bring one-on-one cancer coaching to members

From 14 October, eligible Medibank members living with cancer can access Osara Health's Cancer Coach program for personalised support with the physical and emotional challenges of diagnosis and treatment. SYDNEY, Oct. 14, 2026 /PRNewswire/ -- Osara Health has partnered with Medibank, one of Aust...

2026-10-14 05:11 2891

Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA "Best Start-Up" Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)

SD-101 (Zorblesia™) is the First Topical Therapy Developed to Treat Wounds and Lesions Across the Entire Skin Surface of All Epidermolysis Bullosa (EB) Subtypes This second consecutive nomination places our company and focus on Epidermolysis Bullosa among a select group of visionaries shaping th...

2026-10-14 04:20 2835
1 ... 9101112131415 ... 643